Literature DB >> 10198196

Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing.

J Hao1, H Ju, S Zhao, A Junaid, T Scammell-La Fleur, I M Dixon.   

Abstract

We have previously shown that non-myocytes present in healed 8-week infarct scar overexpress transduction proteins required for initiating the elevated deposition of structural matrix proteins in this tissue. Other work suggests that TGF-beta 1 may be involved in cardiac fibrosis and myocyte hypertrophy. However, the significance of the altered TGF-beta signaling in heart failure in the chronic phase of post-myocardial infarction (MI), particularly in the ongoing remodeling of the infarct scar, remains unexplored. Patterns of cardiac TGF beta 1 and Smad 2, 3, and 4 protein expression were investigated 8 weeks after MI and were compared to relative collagen deposition in border tissues (containing remnent myocytes) and the infarct scar (non-myocytes). Both TGF-beta 1 mRNA abundance and protein levels were significantly increased in the infarct scar v control values, and this trend was positively correlated to increased collagen type I expression. Cardiac Smad 2, 3, and 4 proteins were significantly increased in border and scar tissues v control values. Immunofluorescent studies indicated that Smad proteins localized proximal to the cellular nuclei present in the infarct scar. Decorin mRNA abundance was elevated in border and infarct scar, and the pattern of decorin immunostaining was markedly altered in remote remnant heart and scar v staining patterns of control sections. Expression of T beta RI (53 kDa) protein was significantly reduced in the scar, while the 75 kDa and 110 kDa isoforms of T beta RII were unchanged and significantly increased in scar, respectively. These results indicate that TGF-beta/Smad signaling may be involved in the remodeling of the infarct scar after the completion of wound healing per se, via ongoing stimulation of matrix deposition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198196     DOI: 10.1006/jmcc.1998.0902

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  69 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  Re-employment of developmental transcription factors in adult heart disease.

Authors:  Toru Oka; Jian Xu; Jeffery D Molkentin
Journal:  Semin Cell Dev Biol       Date:  2006-11-24       Impact factor: 7.727

Review 3.  Adhesion proteins, stem cells, and arrhythmogenesis.

Authors:  Nikki Gillum; Narine Sarvazyan
Journal:  Cardiovasc Toxicol       Date:  2008-01-05       Impact factor: 3.231

Review 4.  The epicardium as a hub for heart regeneration.

Authors:  Jingli Cao; Kenneth D Poss
Journal:  Nat Rev Cardiol       Date:  2018-10       Impact factor: 32.419

5.  Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma.

Authors:  Koji Fukui; Shinji Tamura; Akira Wada; Yoshihiro Kamada; Yoshiyuki Sawai; Kazuho Imanaka; Takahiko Kudara; Iichiro Shimomura; Norio Hayashi
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-30       Impact factor: 4.553

6.  Age-related atrial fibrosis.

Authors:  Felix Gramley; Johann Lorenzen; Christian Knackstedt; Obaida R Rana; Erol Saygili; Dirk Frechen; Sven Stanzel; Francesco Pezzella; Eva Koellensperger; Christian Weiss; Thomas Münzel; Patrick Schauerte
Journal:  Age (Dordr)       Date:  2008-10-07

7.  Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.

Authors:  Hongmei Gu; Amanda J Fisher; Elizabeth A Mickler; Frank Duerson; Oscar W Cummings; Marc Peters-Golden; Homer L Twigg; Trent M Woodruff; David S Wilkes; Ragini Vittal
Journal:  FASEB J       Date:  2016-03-08       Impact factor: 5.191

8.  Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease.

Authors:  Zian H Tseng; Eric Vittinghoff; Stacy L Musone; Feng Lin; Dean Whiteman; Ludmila Pawlikowska; Pui-Yan Kwok; Jeffrey E Olgin; Bradley E Aouizerat
Journal:  Heart Rhythm       Date:  2009-08-28       Impact factor: 6.343

9.  Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.

Authors:  Claudia Mera; Iván Godoy; Renato Ramírez; Jackeline Moya; María Paz Ocaranza; Jorge E Jalil
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-10-21

10.  The inflammatory response and cardiac repair after myocardial infarction.

Authors:  Deuk-Young Nah; Moo-Yong Rhee
Journal:  Korean Circ J       Date:  2009-10-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.